Investigation of the efficacy and safety of ipragliflozin in obese patients with type 2 diabetes undergoing metformin (Met)
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2016
Price : $35 *
At a glance
- Drugs Ipragliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 26 May 2016 Status changed from active, no longer recruiting to completed.
- 20 Aug 2015 According to the University Hospital Medical Information Network - Japan record, status changed from recruiting to active, no longer recruiting.
- 15 Aug 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan